{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T21:53:27Z","timestamp":1726437207095},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T00:00:00Z","timestamp":1353542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Blood transfusion safety has had a chequered history, and there are current and future challenges. Internationally, there is no clear consensus for many aspects of the provision of safe blood, although pan\u2010national legislation does provide a baseline framework in the European Union. Costs are rising, and new safety measures can appear expensive, especially when tested against some other medical interventions, such as cancer treatment and vaccination programmes. In this article, it is proposed that a comprehensive approach is taken to the issue of blood transfusion safety that considers all aspects of the process rather than considering only new measures. The need for an agreed level of safety for specified and unknown risks is also suggested. The importance of providing care and support for those inadvertently injured as a result of transfusion problems is also made. Given that the current blood safety decision process often uses a utilitarian principle for decision making \u2013 through the calculation of Quality Adjusted Life Years \u2013 an alternative philosophy is proposed. A social contract for blood safety, based on the principles of \u2018justice as fairness\u2019 developed by John Rawls, is recommended as a means of providing an agreed level of safety, containing costs and providing support for any adverse outcomes.<\/jats:p>","DOI":"10.1111\/j.1365-3148.2012.01200.x","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T06:44:17Z","timestamp":1353566657000},"page":"377-382","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Blood transfusion safety: a new philosophy"],"prefix":"10.1111","volume":"22","author":[{"given":"I. M.","family":"Franklin","sequence":"first","affiliation":[{"name":"National Blood Centre Irish Blood Transfusion Service  Dublin Leister Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,11,22]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"Epicurus. Porphory; Letter to Marcella. 31 [fragment U221 Usener]. Athens; 341BCE\u2010270BCE CA. 300 BCE."},{"key":"e_1_2_12_3_1","first-page":"211","article-title":"Cost\u2010effectiveness of new blood safety technologies","volume":"102","author":"AuBuchon J.P.","year":"2000","journal-title":"Developments in Biologicals,"},{"volume-title":"Report of the Tribunal into the Infection of Patients with HCV Through Anti\u2010D Therapy","year":"1997","author":"Finlay T.A.","key":"e_1_2_12_4_1"},{"volume-title":"Final Report. Commission of Inquiry on the Blood System in Canada","year":"1997","author":"Krever H.","key":"e_1_2_12_5_1"},{"key":"e_1_2_12_6_1","unstructured":"Wall M. HIV and hep C settlements may cost \u20ac2.23bn. The Irish Times 13th December2011."},{"key":"e_1_2_12_7_1","unstructured":"Fletcher V. Swine flu scandal: billions of pounds are wasted on vaccines. Express.co.uk. 5th February2010."},{"key":"e_1_2_12_8_1","unstructured":"HIQA. A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt\u2013Jakob disease transmission in Ireland Dublin Ireland. Health Information & Quality Authority2011."},{"volume-title":"In place of fear","year":"1952","author":"Bevan A.","key":"e_1_2_12_9_1"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.4159\/9780674042605"},{"volume-title":"Leviathan","year":"1651","author":"Hobbes T.","key":"e_1_2_12_11_1"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91370-A"},{"key":"e_1_2_12_13_1","first-page":"308","volume-title":"The BSE Inquiry","author":"Phillips L.","year":"2000"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3148.2012.01200.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3148.2012.01200.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T16:59:59Z","timestamp":1700585999000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3148.2012.01200.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,22]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1365-3148.2012.01200.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3148.2012.01200.x","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"type":"print","value":"0958-7578"},{"type":"electronic","value":"1365-3148"}],"subject":[],"published":{"date-parts":[[2012,11,22]]},"assertion":[{"value":"2012-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-09-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}